The pericarp of the fruits of P. butyracea was separated from the seeds and dried separately.
The ground pericarp (3.2 kg) was extracted at room temperature with a mixture of CH 2 Cl 2 MeOH 1:1 (2  5 L, 24 h each). The solvent was evaporated under reduced pressure to yield 102 g of extract. The ground seeds (2.3 kg) were also extracted at room temperature with CH 2 Cl 2 MeOH 1:1 (2  3 L, 24 h each). The solvent was removed under reduced pressure to yield 57 g of extract. The two extracts then were screened for their antiplasmodial activity; the pericarp extract showed good potency, while the seed extract was inactive.
A portion of 80 g of the pericarp extract was fractionated by flash chromatography over silica gel (70230 mesh, 7  42 cm; Merck), eluted with a gradient of increasing polarity of mixtures of hexaneethyl acetate 100:00:100, resulting in the collection of 80 fractions of 500 mL each, which were combined on the basis of TLC analysis to yield three main fractions: P1P3. Fraction P1 (35.0 g, composed of subfractions 128) was a complex mixture containing essentially oil and thus was not studied. Fraction P2 (17.1 g, composed of subfractions 2953) was subjected to column chromatography over silica gel (230400 mesh, subfractions 5480 (50013,000 mL)] was subjected to column chromatography over silica gel (230400 mesh, 5  42; Merck), eluted with n-hexaneEtOAc mixture 70:30, to yield epicathechin (6) (35 mg). The seed extract, which was inactive on the plasmodium falciparum W2 strain, was not further studied. 
Biological evaluation
This evaluation consisted of two steps: 1) a preliminary test of erythrocyte susceptibility to compounds and extracts and 2) a screening for antiplasmodial activity.
Evaluation of erythrocyte susceptibility to compounds in vitro
A preliminary toxicological assessment was carried out to determine the highest drug concentrations that can be incubated with erythrocytes without any significant damage. This 
Evaluation of the antiplasmodial activity
Plasmodium falciparum strain W2, which is resistant to chloroquine and other antimalarial drugs [2] , was cultured in sealed flasks at 37 C (in an atmosphere of 3% O 2 , 5% CO 2 , and 91% N 2 ) in RPMI 1640 medium and 25 mM HEPES, pH 7.4, supplemented with heatinactivated 10% human serum and human erythrocytes to achieve a 2% hematocrit. Parasites were synchronized in the ring stage by serial treatment with 5% sorbitol (Sigma) [3] and studied at 1% parasitemia.
Stock solutions of plant products were prepared as 1 mg/mL in DMSO, diluted as needed for individual experiments, and tested in triplicate. The stock solutions were diluted in supplemented RPMI 1640 medium so as to have at most 0.2% DMSO in the final reaction
medium. An equal volume of 1% parasitemia, 4% hematocrit culture was thereafter added and gently mixed thoroughly. Negative controls contained equal concentrations of DMSO.
Positive controls contained 1 M chloroquine phosphate (Sigma). Cultures were incubated at 37 C for 48 h (1 parasite erythrocytic life cycle).
Parasites at ring stage were thereafter fixed by replacing the serum medium with an equal volume of 1% formaldehyde in PBS. Aliquots (50 L) of each culture were then added to 5- , where H is the hill coefficient or slope factor [2] .
